InsidersTradesSigma
基于 4 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Mehra Anand, 董事. Director active across 1 company, notably Aclaris Therapeutics, Inc.. In total, 5 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €1.4m. History available since 19 November 2024. The latest transaction was filed on 19 November 2024 (Acquisition). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Anand Mehra is a Board Member at Aclaris Therapeutics, Inc. He oversees the company's operations and participates in strategic decision-making. Anand is committed to promoting strong governance practices and ensuring regulatory compliance.